Title:
Raltegravir
Source:
Nature Reviews Drug Discovery [1474-1776] Deeks, Steven yr:2008 vol:7 iss:2 pg:117 -118
Full Text Online
Nature
Available from 2002 volume: 1 issue:1
Request
through RightFind document delivery
*
User ID (e.g., jroppen):
Users interested in this article also expressed an interest in the following:
description
1.
Cahn, P.
"Raltegravir: a new antiretroviral class for salvage therapy."
The lancet
369.9569 (2007): 1235-6.
description
2.
Joy, T.
"Is raising HDL a futile strategy for atheroprotection?"
Nature reviews. Drug discovery
7.2 (2008): 143-155.
description
3.
Liedtke, M.
"Long-term efficacy and safety of raltegravir in the management of HIV infection."
Infection and Drug Resistance
7 (2014): 73-84.
description
4.
Croxtall, Caroline M D.
Drugs
68.1 (2008): 131-138.
description
5.
Isaacs, Robin D D.
"Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial."
The lancet
369.9569 (2007): 1261-9.
View More...
View Less...
Select All
Clear All
Save Citations
Select Format
ProCite
EndNote
Submit citation export
More Options
Need Research Help? Have a question?
Ask a Librarian
Library Reference
Report
Problems, Errors, etc.
Find related information in
Google Scholar
Article Title
Author Name
Journal Title
Other Search
Search Terms:
Powered by
SFX
&
bX
© 2010 Ex Libris Inc.
CrossRef
Enabled